Detailed answers about THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED, including incorporation, status, business activity, and accounts information.
When was THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED founded?
THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED was officially incorporated on 5 December 2001 and is registered under company number 04334810. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED?
THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED do?
THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED's registered address?
The registered office address of THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED is BRISTOL ROYAL INFIRMARY, MARLBOROUGH STREET, BRISTOL, ENGLAND, BS2 8HW. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED financially stable?
The most recent accounts for THE BRISTOL & AVON DERMATOLOGY RESEARCH TRUST LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.